Drugs in early clinical development for Systemic Lupus Erythematosus
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drugs in early clinical development for Systemic Lupus Erythematosus
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 5, Pages 573-583
Publisher
Informa Healthcare
Online
2016-03-08
DOI
10.1517/13543784.2016.1162291
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obinutuzumab in hematologic malignancies: Lessons learned to date
- (2015) Tim Illidge et al. CANCER TREATMENT REVIEWS
- Immunogenetics of systemic lupus erythematosus: A comprehensive review
- (2015) Yogita Ghodke-Puranik et al. JOURNAL OF AUTOIMMUNITY
- Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations
- (2015) Shruti Sharma et al. JOURNAL OF AUTOIMMUNITY
- First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus
- (2015) A Tocoian et al. LUPUS
- T cells as a therapeutic target in SLE
- (2015) D Comte et al. LUPUS
- Interferon regulatory factors: critical mediators of human lupus
- (2015) Mark A. Jensen et al. Translational Research
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
- (2014) R A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
- (2014) Chi Chiu Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- The efficacy of novel B cell biologics as the future of SLE treatment: A review
- (2014) Ameer Kamal et al. AUTOIMMUNITY REVIEWS
- Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies
- (2014) Zozik Fattah et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Sirukumab: a novel therapy for lupus nephritis?
- (2014) Uma Thanarajasingam et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New treatments for inflammatory rheumatic disease
- (2014) Carlo Selmi et al. IMMUNOLOGIC RESEARCH
- Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus
- (2014) Zev Sthoeger et al. JOURNAL OF AUTOIMMUNITY
- Long-term data on tacrolimus treatment in lupus nephritis
- (2014) Desmond Y. H. Yap et al. RHEUMATOLOGY
- A 2014 update on the management of patients with systemic lupus erythematosus
- (2014) Joan T. Merrill et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study
- (2014) Arthritis & Rheumatology
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
- (2013) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Sifalimumab, a Human Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study
- (2013) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity
- (2013) Li Zhang et al. CLINICAL IMMUNOLOGY
- Pharmacogenomics and Translational Simulations to Bridge Indications for an Anti-Interferon-α Receptor Antibody
- (2013) B Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis
- (2013) B Duxbury et al. LUPUS
- Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases
- (2013) Jing Li et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients
- (2013) Kichul Ko et al. Frontiers in Immunology
- Recent progress in conventional and biologic therapy for systemic lupus erythematosus
- (2012) David Wofsy ANNALS OF THE RHEUMATIC DISEASES
- Effect of IL-17A blockade with secukinumab in autoimmune diseases
- (2012) Dhavalkumar D Patel et al. ANNALS OF THE RHEUMATIC DISEASES
- Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial
- (2012) Robert Zimmer et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
- (2012) Susan Manzi et al. ANNALS OF THE RHEUMATIC DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid
- (2012) Bernard R. Lauwerys et al. ARTHRITIS AND RHEUMATISM
- B cell elimination in systemic lupus erythematosus
- (2012) João Furtado et al. CLINICAL IMMUNOLOGY
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- Targeted therapies in systemic lupus erythematosus: successes, failures and future
- (2011) B. H. Hahn ANNALS OF THE RHEUMATIC DISEASES
- B lymphocyte stimulator levels in systemic lupus erythematosus: Higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels
- (2011) Lauren L. Ritterhouse et al. ARTHRITIS AND RHEUMATISM
- Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
- (2011) H. Travis Ichikawa et al. ARTHRITIS AND RHEUMATISM
- The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus
- (2011) Mariana Postal et al. CYTOKINE
- Plasma cells in systemic lupus erythematosus: The long and short of it all
- (2011) Zheng Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Preclinical studies with synthetic peptides in systemic lupus erythematosus
- (2011) Gil Amarilyo Frontiers in Bioscience-Landmark
- Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE
- (2011) Matthew M. Seavey et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Current and novel therapeutics in the treatment of systemic lupus erythematosus
- (2011) Cagri Yildirim-Toruner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice
- (2011) BJ Skaggs et al. LUPUS
- Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report
- (2011) M Aringer et al. LUPUS
- The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation
- (2011) T. Turner-Stokes et al. RHEUMATOLOGY
- Novel treatments for systemic lupus erythematosus
- (2011) Wen Xiong et al. Therapeutic Advances in Musculoskeletal Disease
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
- (2010) Corinna E. Weckerle et al. ARTHRITIS AND RHEUMATISM
- Biologics in the treatment of systemic lupus erythematosus
- (2010) Aisha Lateef et al. CURRENT OPINION IN RHEUMATOLOGY
- Anticytokine therapies in systemic lupus erythematosus
- (2010) Antonio La Cava Immunotherapy
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Pharmacotherapy of systemic lupus erythematosus
- (2009) Lisa Francis et al. EXPERT OPINION ON PHARMACOTHERAPY
- Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: Results of an early phase II clinical trial
- (2008) Sylviane Muller et al. ARTHRITIS AND RHEUMATISM
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started